Atara Biotherapeutics【ATRA】株式ニュース

名称	銘柄コード	市場	種別
Atara Biotherapeutics Inc	ATRA	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	-0.0291	-5.11%	0.54	00:54:14

始値	安値	高値	終値	前日終値
0.57	0.52	0.57		0.5691

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/6/06	05:01	BW	Atara Biotherapeutics to Participate in the Goldman Sachs..
2024/5/30	05:01	BW	Atara Biotherapeutics Presents Preclinical Data on ATA3219,..
2024/5/23	07:18	EDGAR2	Form SC 13D - General statement of acquisition of beneficial..
2024/5/21	09:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/21	09:34	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/21	09:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/21	09:33	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/21	09:32	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/20	22:25	BW	Atara Biotherapeutics Submits Tabelecleucel (Tab-cel®)..
2024/5/17	10:15	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/17	10:14	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/17	10:14	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/17	10:13	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/17	10:13	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/17	09:55	EDGAR2	Form 144 - Report of proposed sale of securities
2024/5/11	05:30	EDGAR2	Form DEFR14A - Revised definitive proxy soliciting materials
2024/5/10	05:11	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/10	05:05	EDGAR2	Form 8-K - Current report
2024/5/10	05:01	BW	Atara Biotherapeutics Announces First Quarter 2024 Financial..
2024/5/04	05:01	BW	Atara Biotherapeutics, Inc. Reports Inducement Grant Under..
2024/4/06	05:01	BW	Atara Biotherapeutics, Inc. Reports Inducement Grant Under..
2024/3/28	21:30	BW	Atara Biotherapeutics Announces Fourth Quarter and Full Year..
2024/3/07	08:17	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/07	08:16	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/3/05	10:21	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/05	10:19	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/05	10:18	EDGAR2	Form 144 - Report of proposed sale of securities
2024/3/05	10:17	EDGAR2	Form 144 - Report of proposed sale of securities
2024/2/29	23:05	BW	Atara Biotherapeutics Receives FDA Clearance of IND..
2024/2/29	06:30	BW	Atara Biotherapeutics to Participate in Cell Therapy Panel..
2024/2/24	06:30	EDGAR2	Form 8-K - Current report
2024/2/14	23:00	BW	Atara Biotherapeutics Announces Submission of..
2024/2/01	16:25	PRNUS	Atara Biotherapeutics and Pierre Fabre Laboratories Announce..
2024/2/01	08:30	BW	Atara Biotherapeutics and Pierre Fabre Laboratories Announce..
2024/1/10	06:41	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/10	06:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/10	06:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/10	06:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/10	06:40	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/10	06:28	EDGAR2	Form 424B5 - Prospectus [Rule 424(b)(5)]
2024/1/10	06:01	EDGAR2	Form 8-K - Current report
2024/1/08	23:00	BW	Atara Biotherapeutics Announces $15 Million Registered..
2024/1/08	22:11	EDGAR2	Form 8-K - Current report
2024/1/08	22:00	BW	Atara Biotherapeutics to Present Recent Progress and Key..
2024/1/05	06:01	BW	Atara Biotherapeutics to Present at the 42nd Annual J.P...
2024/1/04	06:09	EDGAR2	Form S-8 - Securities to be offered to employees in employee..
2023/12/21	06:30	EDGAR2	Form 8-K - Current report
2023/12/21	06:01	BW	Atara Biotherapeutics Announces Closing of Expanded Global..
2023/12/12	02:00	BW	Atara Biotherapeutics Presents Positive Preclinical Data on..
2023/12/02	06:01	BW	Atara Biotherapeutics, Inc. Reports Inducement Grants Under..